Drug profile · INN
insulin susp isophane recombinant human
HUMULIN N
insulin susp isophane recombinant human (HUMULIN N) is a insulin receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — insulin susp isophane recombinant human
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
insulin susp isophane recombinant human (HUMULIN N) is a insulin receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Insulin receptor agonist
Primary target: Insulin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is insulin susp isophane recombinant human?
insulin susp isophane recombinant human (HUMULIN N) is a insulin receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for insulin susp isophane recombinant human?
HUMULIN N is a marketed brand name for insulin susp isophane recombinant human. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of insulin susp isophane recombinant human?
insulin susp isophane recombinant human has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.